Skip to main content
. 2019 Aug 22;146(16):dev175158. doi: 10.1242/dev.175158

Fig. 8.

Fig. 8.

Enhancer mutagenesis analysis in vivo. (A) Schematic of 717-lacZ, 717-Dsxmutant-lacZ, 717-AbdBmutant-lacZ and 717-Coopmutant-lacZ. (B-F) Shows the enhancer-lacZ expression for wild-type and various mutant versions of the enhancer in Dsx+tNBs at mid-L2. 717-lacZ expresses normally (n=21) (B″) but Dsxmutant-lacZ (n=14) (C″) and Coopmutant-lacZ (n=12) (F″) fail to express in Dsx+tNBs of female VNCs in mid-L2. AbdBmutant-lacZ expression is unaffected in Dsx+tNBs of females (n=9) (D″), but male VNCs show ectopic expression in Dsx+tNBs where it is normally not expressed (n=11) (E″). In contrast, Dsxmutant-lacZ expression is not observed in either male (n=15) (G-G‴) or cell death-blocked female VNCs (n=8) (H-H″″) in late L3 (Fig. S2A for TS protocol). n indicates the number of VNCs analysed. Yellow arrowheads indicate Dsx+tNBs. Scale bars: 10 µm. All the images are single confocal sections.